Jesus Francisco Saltaren Fonseca

Dr. Jesus Francisco Saltaren Fonseca

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
FMFedor Wadi Richani Meinhardt
Fedor Wadi Richani Meinhardt
MIMijail Ivan Zambrano Iglesias
Mijail Ivan Zambrano Iglesias
Maria Paula Fernandez GomezMaria Paula Fernandez Gomez
Maria Paula Fernandez Gomez
JFJesus Francisco Saltaren Fonseca
Jesus Francisco Saltaren Fonseca
Atif HusseinAtif Hussein
Atif Hussein
LRLuis E Raez
Luis E Raez
This review discusses the role of human epidermal growth factor receptor 2 (HER2/ERBB2) as a key oncogenic driver in non-small cell lung cancer (NSCLC), including exon 20 activating mutations, gene amplification, and protein overexpression. These forms differ in their biological effects and predictive value, but HER2 mutations, especially exon 20 insertions, are the primary oncogenic mechanism. Regarding diagnosis, Next-Generation Sequencing (NGS) is used to identify mutations, whereas Immunohistochemistry (IHC) and in situ hybridization are used to assess HER2 expression. Concerning treatment, in advanced HER2-positive, Non-Squamous NSCLC tumors, the first-line treatment is Platinum-based + Pemetrexed chemotherapy, with or without immunotherapy, because no HER2-targeted antibody therapy has yet been approved for initial treatment. After progression, HER2-targeted antibody-drug conjugates like Trastuzumab-Deruxtecan and Ado Trastuzumab-Emtansine may offer patients clinical benefits. New HER2-selective tyrosine kinase inhibitors, such as zongertinib and sevabertinib, have shown promising results, including patients previously treated with antibody–drug conjugates (ADCs). Recent advances, including next-generation ADCs such as SHR-A1811 and A166, and bispecific antibodies, such as zenocutuzumab for NRG1 fusion–positive disease, which are also expanding treatment options. Overall, advances in diagnostics and new targeted therapies are changing how HER2-altered NSCLC is treated and are helping to make care more personalized.

7 January 2025 in Ciencia Latina Revista Científica Multidisciplinar
Verified
Journal Article
Open access
PDF file
VAValentina Linares Abella
Valentina Linares Abella
JFJesus Francisco Saltaren Fonseca
Jesus Francisco Saltaren Fonseca
RMRubén Dario Chicaiza Maya
Rubén Dario Chicaiza Maya
JAJuan Pablo Barrios Avilez
Juan Pablo Barrios Avilez
JCJairo Alejandro Otero Coral
Jairo Alejandro Otero Coral
MMMayra Lisseth Diaz Mina
Mayra Lisseth Diaz Mina
Antecedentes: La cirugía hepatobiliar es una especialidad quirúrgica enfocada en tratar enfermedades del hígado, las vías biliares y la vesícula biliar. Estas estructuras desempeñan un papel esencial en funciones metabólicas como la producción de bilis, la eliminación de toxinas y el metabolismo de nutrientes. Entre las afecciones más comunes que requieren intervención quirúrgica se encuentran cánceres hepáticos primarios (como el carcinoma hepatocelular) y tumores metastásicos que afectan al hígado desde otros órganos.Metodología: Se llevó a cabo una revisión sistemática, en la que se realizaron búsquedas en las bases de datos de PubMed, Scielo y ScienceDirect, entre otras. Teniendo en cuenta los siguientes criterios de Inclusión estudios primarios que describan técnicas quirúrgicas actuales o emergentes en cirugía hepatobiliar, como resecciones hepáticas, trasplante hepático, y procedimientos en la vesícula biliar, estudios publicados en los últimos 10 años, para asegurar la inclusión de las últimas innovaciones en el campo, estudios en humanos que involucren procedimientos de cirugía hepatobiliar. Resultados: La cirugía hepatobiliar ha evolucionado significativamente en las últimas décadas, transformándose gracias al avance de las tecnologías médicas y quirúrgicas. Este campo, que abarca procedimientos complejos como la resección hepática, el trasplante de hígado y la cirugía de vías biliares. El estudio de las nuevas técnicas en cirugía hepatobiliar es fundamental para el avance de la medicina y la mejora de la calidad de vida de los pacientes. Las fortalezas de este campo incluyen la reducción del trauma quirúrgico y de las complicaciones postoperatorias, así como la mejora de los resultados a largo plazo gracias a la personalización de los procedimientos y la mayor precisión.Conclusiones: Las nuevas técnicas en cirugía hepatobiliar están revolucionando el campo, ofreciendo soluciones más seguras, eficaces y menos invasivas. La integración de tecnologías como la cirugía robótica, la navegación guiada por imágenes y las terapias ablativas está mejorando significativamente los resultados clínicos y la calidad de vida de los pacientes.

13 November 2025 in Cureus
Verified
Journal Article
Open access
PDF file
JFJesus Francisco Saltaren Fonseca
Jesus Francisco Saltaren Fonseca
VRValeria Rojas Ruiz
Valeria Rojas Ruiz
JSJesus Francisco Saltaren
Jesus Francisco Saltaren
JLJuan Nicolas Daza Lopez
Juan Nicolas Daza Lopez
AHAndres Camilo Herrera
Andres Camilo Herrera
DADiego Fernando Arango Ardila
Diego Fernando Arango Ardila
Reconstruction of complex traumatic chest wall defects, particularly those complicated by necrotizing fasciitis (NF), requires a meticulous and individualized surgical approach. This case report describes the successful management of a 46-year-old male patient with post-traumatic NF involving the scapular region. After multiple surgical debridements and negative pressure wound therapy, definitive reconstruction was achieved using a chimeric trapezius muscle flap, providing both defect coverage and functional restoration. This case highlights the utility of the trapezius flap in managing challenging chest wall defects, particularly when alternative flap options are limited, and underscores the critical role of a multidisciplinary approach in the treatment of severe soft tissue infections.

16 June 2026 in Reports
Verified
Journal Article
Open access
PDF file
Maria Paula Fernandez GomezMaria Paula Fernandez Gomez
Maria Paula Fernandez Gomez
Luis Rafael Moscote-SalazarLuis Rafael Moscote-Salazar
Luis Rafael Moscote-Salazar
JFJesus Francisco Saltaren Fonseca
Jesus Francisco Saltaren Fonseca
GVGuillermo de Jesús Aguirre Vera
Guillermo de Jesús Aguirre Vera
WMWillem Calderon Miranda
Willem Calderon Miranda
JVJose Valerio
Jose Valerio
Background and Clinical Significance: Tumefactive Multiple Sclerosis (TMS) represents a rare and diagnostically challenging form of demyelinating disease characterized by large space-occupying lesions that can closely mimic intracranial neoplasms, abscesses, and other inflammatory or vascular conditions. Case Presentation: The case highlights the overlapping radiologic features that frequently lead to diagnostic uncertainty and underscores the importance of careful interpretation of multimodal imaging and ancillary studies. Overall a comprehensive multidisciplinary evaluation is essential to reduce the risk of misdiagnosis and avoid unnecessary invasive interventions. Conclusions: This review summarizes current evidence regarding the diagnostic approach, imaging characteristics, and therapeutic strategies for tumefactive demyelinating lesions. Additionally, we present a clinical case that illustrates the diagnostic complexity of this entity, in which neuroimaging findings and cerebrospinal fluid analysis supported a demyelinating rather than neoplastic process.